Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseasesRebecca Hasseli, Jutta G. Richter, Bimba Franziska Hoyer, Hanns-Martin Lorenz, Alexander Pfeil, Anne Constanze Regierer, Tim Schmeiser, Anja Strangfeld, Reinhard E Voll, Andreas Krause, Sabine Reckert, Anett Gräßler, Petra Saar, Andreas Kapelle, Marina BackhausSee the full list of authors
17 April 2023
Should we stop methotrexate or not for vaccination?Patrick Durez, Bernard Combe
4 April 2023
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER studyJosé M Álvaro-Gracia, Carlos Sanchez-Piedra, Dante Culqui, Rosa Rosello, Alicia Garcia-Dorta, Cristina Campos, Sara Manrique-Arija, Dolores Ruiz-Montesinos, Inmaculada Ros-Vilamajo, Carlos Rodríguez-Lozano, Mercedes Freire-González, Rafael Caliz, Cristina Bohorquez, Lourdes Mateo Soria, Noemí BusquetsSee the full list of authors
16 March 2023
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population studyXiaofeng Jiang, Jeffrey Sparks, Zachary Wallace, Xinjia Deng, Hui Li, Na Lu, Dongxing Xie, Yilun Wang, Chao Zeng, Guanghua Lei, Jie Wei, Yuqing Zhang
8 March 2023
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)Ai Phuong Tran, D.F Tassone, N S Ding, Johannes Nossent
2 March 2023
Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case seriesChathurika Lakmini Dandeniya, Theekshana Kavinda Premathilake
14 February 2023
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case seriesAlexander ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N. Albach
6 December 2022
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic diseaseLeonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander ten Hagen, Elisa Habermann, Florian Kurth, Leif Erik Sander, Victor Max Corman, Gerd-Rüdiger Burmester, Robert BiesenSee the full list of authors
6 December 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joe Sexton, Ingrid Egeland Christensen, Trung T Tran, Kristin Hammersbøen Bjørlykke, Siri Mjaaland, David J Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jorgen Jahnsen, Ludvig A Munthe, Espen A HaavardsholmSee the full list of authors
3 November 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RAKristin Schmiedeberg, Irene A Abela, Natalia Barbara Pikor, Nicolas Vuilleumier, Magdalena Schwarzmueller, Selina Epp, Sabrina Pagano, Sarah Grabherr, Angelica Brooke Patterson, Madalina Nussberger, Alexandra Trkola, Burkhard Ludewig, Johannes von Kempis, Andrea Rubbert-Roth
26 October 2022
